Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis

被引：0
|
作者：
Haizhu Chen
Yu Feng
Yu Zhou
Yunxia Tao
Le Tang
Yuankai Shi
机构：
[1] Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical
来源：
Cancer Immunology, Immunotherapy | 2022年 / 71卷
关键词：
Non-small cell lung cancer; Immune checkpoint inhibitor; Brain metastases; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3071 / 3085
页数：14
相关论文
共 50 条
  • [41] The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non-Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review
    Chai, Qing-Qing
    Du, Jiang-Yang
    Zhu, Jun
    Wu, Bin
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [42] Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer
    Aung, Wint Yan
    Lee, Chung-Shien
    Morales, Jaclyn
    Kohn, Nina
    Rahman, Husneara
    Seetharamu, Nagashree
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Effect and safety of immune checkpoint inhibitors for brain metastases from non-small cell lung cancer
    Iuchi, T.
    Ashinuma, H.
    Yoshida, Y.
    Mizuno, S.
    Hosono, J.
    Setoguchi, T.
    Hasegawa, Y.
    Sakaida, T.
    Shingyoji, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 622 - 622
  • [44] Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: A systematic evaluation and meta-analysis
    Lu, Yu
    Zhang, Xiaoyan
    Ning, Jiyu
    Zhang, Manyan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [45] Immune Checkpoint Inhibitors for Brain Metastases of Non-Small-Cell Lung Cancer
    Ashinuma, H.
    Shingyoji, M.
    Iuchi, T.
    Yoshida, Y.
    Setoguchi, T.
    Hasegawa, Y.
    Sakaida, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2420 - S2420
  • [46] ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis
    Elliott, Jesse
    Bai, Zemin
    Hsieh, Shu-Ching
    Kelly, Shannon E.
    Chen, Li
    Skidmore, Becky
    Yousef, Said
    Zheng, Carine
    Stewart, David J.
    Wells, George A.
    PLOS ONE, 2020, 15 (02):
  • [47] ALK inhibitors in ALK-rearranged non-small cell lung cancer with and without brain metastases: systematic review and network meta-analysis
    Jiang, Jun
    Zhao, Cong
    Zhang, Fang
    Liu, Zhenhua
    Zhou, Kaiyuan
    Ren, Xinling
    Wan, Yi
    BMJ OPEN, 2022, 12 (09):
  • [48] Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis
    Xia, Handai
    Zhang, Wengang
    Zhang, Yuqing
    Shang, Xiaoling
    Liu, Yanguo
    Wang, Xiuwen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] The efficacy and safety of combination therapy with immune checkpoint inhibitors in non-small cell lung cancer: A meta-analysis
    Mo, Dun-Chang
    Huang, Jian-Feng
    Luo, Peng-Hui
    Huang, Shang-Xiao
    Wang, Han-Lei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [50] Immune checkpoint proteins as a prognostic biomarker of overall survival in non-small cell lung cancer: A meta-analysis and systematic review
    Tan, H. N.
    Rodriguez, C. C.
    Monte, K. A.
    Tan, P. G.
    Cornelio, G. D. H.
    ANNALS OF ONCOLOGY, 2020, 31 : S283 - S283
12345